Special Issues
Biomedicines publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Pathophysiology and Therapeutic Perspectives in DMD: The Well-Defined Role of the Immune System
Deadline: 31 August 2021
Anti-inflammatory Activity of Plant Polyphenols 2.0
Deadline: 15 September 2021
Optical Nanoparticles for Biomedicine
Deadline: 30 September 2021
Hypertension and Cardiovascular Diseases: From Etiopathogenesis to Potential Therapeutic Targets
Deadline: 30 September 2021
Mechanisms and Novel Therapeutic Approaches for Gynecologic Cancer
Deadline: 30 September 2021
Biomarkers and New Therapeutical Strategies for Cancer Diagnosis and Treatment
Deadline: 30 September 2021
Drug Transporters
Deadline: 15 October 2021
Antibody Based Delivery of Toxins and Other Active Molecules for Cancer Therapy
Deadline: 31 October 2021
Brain Injury and Neurodegeneration: Molecular, Functional, and Translational Approach
Deadline: 31 October 2021
Advancements in the Treatment of Spinal Cord Injury
Deadline: 31 October 2021
Cancer Metabolism and Resistance to Cell Death: Novel Therapeutic Perspectives
Deadline: 31 October 2021
Adipose-Derived Mesenchymal Stem Cells, Cell-Based Therapies, and Biomaterials as New Regenerative Strategies
Deadline: 31 October 2021
of 156

